Status:
COMPLETED
Relative Bioavailability of of Olodaterol and Ketoconazole
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Healthy
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
21-50 years
Phase:
PHASE1
Brief Summary
This clinical trial is intended to investigate a possible effect of the p-gp inhibitor ketoconazole on the bioavailability of olodaterol
Eligibility Criteria
Inclusion
- Inclusion criteria Healthy male and female volunteers
- Exclusion criteria
Exclusion
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT01153711
Start Date
May 1 2010
Last Update
April 30 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1222.47.1 Boehringer Ingelheim Investigational Site
Ingelheim, Germany